3 New Strong Buy Ratings from Top-Rated Analysts: 02/05/2026
3 very different stocks, but one thing in common: Analysts call them Strong Buys. Here’s what’s up:
- Northrop Grumman (NOC): Defense giant riding record contracts and global tensions
- HCA Healthcare (HCA): America’s hospital powerhouse beats earnings, raises outlook
- Corning (GLW): Glass innovator surging on AI, solar demand
P.S. Want more like these? We curated a collection of 3 stocks with MASSIVE upside potential … Get them here
1. Northrop Grumman (NYSE: NOC)
This advanced defense systems manufacturer is trading near its 52-week high, the defense giant benefits from sustained government spending and a robust contract pipeline that positions it well for continued growth.
Zen Rating: B (Buy) — see full analysis
Recent Price: $688.38 — get current quote
Max 1-year forecast: $815.00
Why we're watching:
- Analyst support: Among the 13 analysts we track issuing ratings on NOC, it has 8 Strong Buy ratings, 1 Buy, and 4 Hold ratings, achieving a Strong Buy consensus. See the ratings
- RBC Capital's Kenneth Herbert (a top 1% rated analyst) maintained his Buy rating with a $750 price target, viewing NOC as a defensive option in the current market environment with stable earnings growth driven by solid defense contracts.
- BTIG's Andre Madrid (a top 7% rated analyst) maintained his Strong Buy rating with the highest price target of $815, representing +18.97% upside, citing NOC's exceptional blend of innovation and strong contract backlog.
- Industry ranking context: NOC is currently the #14 highest-rated stock in the Defense industry, which has an Industry Rating of C.
- Zen Rating highlights: NOC is a B (Buy) rated stock; stocks with this rating have historically generated 19.88% annual returns.
- Component Grades: Northrop Grumman has above-average grades in several areas, including Value, Growth, Momentum, Safety, and Financials. (See all 7 Zen Component Grades here)
2. HCA Healthcare (NYSE: HCA)
HCA Healthcare operates 186 hospitals and over 2,000 sites of care across the United States, making it the nation's largest for-profit hospital operator. The company delivered exceptional Q4 results with strong patient volumes and raised guidance, demonstrating resilience in an evolving healthcare landscape.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $492.46 — get current quote
Max 1-year forecast: $598.00
Why we're watching:
- Analyst support: We track 17 analysts who rate the stock — it has 9 Strong Buy ratings, 3 Buy, 4 Hold, and 1 Strong Sell (Overall Buy consensus). See the ratings
- Jefferies' Brian Tanquilut (a top 14% rated analyst) maintained his Strong Buy rating with a $590 price target following the company's strong Q4 performance, representing +18.75% upside potential.
- Truist Securities' David S Macdonald (a top 11% rated analyst) remains optimistic about HCA's ability to sustain strong patient volume trends while expanding margins through operational improvements.
- Industry ranking context: HCA is currently the #5 highest-rated stock in the Medical Care Facility industry, which has an Industry Rating of A.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — the company's strong competitive position and execution track record support continued outperformance.
- Component Grades: HCA demonstrates balanced strength with B grades in Value, Sentiment, Safety, Financials, and AI, though Growth and Momentum earn C ratings as the market digests recent gains. (See all 7 Zen Component Grades here)
3. Corning Inc (NYSE: GLW)
This company specializes in specialty glass, ceramics, and advanced optics for industrial, scientific, and consumer applications. Its "Springboard" program has driven remarkable success, adding $4B to annualized sales while strong demand for Gen AI and solar products positions Corning for significant future growth.
Zen Rating: B (Buy) — see full analysis
Recent Price: $106.93 — get current quote
Max 1-year forecast: $125.00
Why we're watching:
- Analyst support: 8 analysts we track cover GLW; it has 5 Strong Buy ratings, 1 Buy, and 2 Hold ratings, achieving a Strong Buy consensus. See the ratings
- Citigroup's Asiya Merchant (a top 1% rated analyst) recently maintained her Strong Buy rating with a $120 price target, remaining optimistic about Corning's strong position in the solar market and substantial growth potential from the Apple partnership.
- Susquehanna's Mehdi Hosseini (a top 1% rated analyst) maintained his Strong Buy rating with the highest price target of $125 (+13.27% upside), emphasizing Corning's unique market position and technological advancements in glass manufacturing that bolster its competitive advantage.
- Argus Research's Jim Kelleher (a top 7% rated analyst) noted that Q3 2025's record-breaking revenue and earnings were driven by continued success in Optical Communications, with management showing optimism about the Springboard program generating an additional $4B to $6B in annual income within three years.
- Industry ranking context: GLW is currently the #7 highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.
- Zen Rating highlights: Buy (B) stocks average +19.88%/yr — in GLW’s case, this is supported by analysts forecasting impressive earnings growth of +95.48% in the next year and revenue growth of +24.3%.
- Component Grades: Corning shows particular strength with an A grade in Momentum and B grades in Value and Financials, while Growth, Sentiment, Safety, and AI components earn C ratings. (See all 7 Zen Component Grades here)
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.